SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001544227-21-000010
Filing Date
2021-03-02
Accepted
2021-03-02 17:18:10
Documents
1
Period of Report
2021-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161472344947814.html 4  
1 FORM 4 wf-form4_161472344947814.xml 4 4335
  Complete submission text file 0001544227-21-000010.txt   5874
Mailing Address C/O IDERA PHARMACEUTICALS 167 SYDNEY ST CAMBRIDGE MA 02139
Business Address
Arcudi III Louis J (Reporting) CIK: 0001419350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 21705170

Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations